These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 8970874)
21. A comparison of two MR hepatobiliary gadolinium chelates: Gd-BOPTA and Gd-EOB-DTPA. Runge VM J Comput Assist Tomogr; 1998; 22(4):643-50. PubMed ID: 9676461 [TBL] [Abstract][Full Text] [Related]
22. Acute hemodynamic effects of recently developed monomer and dimer magnetic resonance imaging contrast media: a comparative study. Geschwind JF; Saeed M; Wendland MF; Szolar D; Derugin N; Higgins CB Acad Radiol; 1996 Aug; 3(8):667-77. PubMed ID: 8796731 [TBL] [Abstract][Full Text] [Related]
23. Magnetic resonance imaging contrast media in the subarachnoid space. A comparison between gadodiamide injection and gadopentetate dimeglumine in an experimental study in pigs. Skalpe IO; Tang GJ Invest Radiol; 1997 Mar; 32(3):140-8. PubMed ID: 9055126 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of two new gadolinium chelates as contrast agents for MRI. Wiegers CB; Welch MJ; Sharp TL; Brown JJ; Perman WH; Sun Y; Motekaitis RJ; Martell AE Magn Reson Imaging; 1992; 10(6):903-11. PubMed ID: 1461088 [TBL] [Abstract][Full Text] [Related]
25. Clearance of gadolinium chelates by hemodialysis: an in vitro study. Choyke PL; Girton ME; Vaughan EM; Frank JA; Austin HA J Magn Reson Imaging; 1995; 5(4):470-2. PubMed ID: 7549213 [TBL] [Abstract][Full Text] [Related]
26. Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents. Lohrke J; Frisk AL; Frenzel T; Schöckel L; Rosenbruch M; Jost G; Lenhard DC; Sieber MA; Nischwitz V; Küppers A; Pietsch H Invest Radiol; 2017 Jun; 52(6):324-333. PubMed ID: 28323657 [TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics in rats, dogs and monkeys of a gadolinium chelate used as a liver-specific contrast agent for magnetic resonance imaging. Schuhmann-Giampieri G; Frenzel T; Schmitt-Willich H Arzneimittelforschung; 1993 Aug; 43(8):927-31. PubMed ID: 8216456 [TBL] [Abstract][Full Text] [Related]
28. Does gadolinium-diethylene triamine pentaacetic acid enhanced MRI of kidney represent tissue concentration of contrast media in the kidney? In vivo and in vitro study. Takeda M; Katayama Y; Tsutsui T; Komeyama T; Mizusawa T Magn Reson Imaging; 1994; 12(3):421-7. PubMed ID: 8007771 [TBL] [Abstract][Full Text] [Related]
29. Brain distribution of MRI contrast media in rats after intracisternal injection. Allard M; Kien P; Caille JM; Bonnemain B; Simonnet G J Neuroradiol; 1987; 14(4):383-7. PubMed ID: 3131496 [No Abstract] [Full Text] [Related]
30. In vivo stability and excretion of gadodiamide (GdDTPA-BMA), a hydrophilic gadolinium complex used as a contrast enhancing agent for magnetic resonance imaging. Normann PT; Hals PA Eur J Drug Metab Pharmacokinet; 1995; 20(4):307-13. PubMed ID: 8983938 [TBL] [Abstract][Full Text] [Related]
31. Revisiting the Pharmacokinetic Profiles of Gadolinium-Based Contrast Agents: Differences in Long-Term Biodistribution and Excretion. Lancelot E Invest Radiol; 2016 Nov; 51(11):691-700. PubMed ID: 27175546 [TBL] [Abstract][Full Text] [Related]
32. Acute hemodynamic effects of nonionic and ionic magnetic resonance contrast media in intravenous bolus injection in rats. Masui T; Takehara Y; Aoshima R; Kaneko M Invest Radiol; 1994 Jun; 29 Suppl 2():S189-91. PubMed ID: 7928226 [No Abstract] [Full Text] [Related]
33. Mannan-coated liposome delivery of gadolinium-diethylenetriaminepentaacetic acid, a contrast agent for use in magnetic resonance imaging. Kunimasa J; Inui K; Hori R; Kawamura Y; Endo K Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2565-7. PubMed ID: 1446380 [TBL] [Abstract][Full Text] [Related]
35. Neurotoxicity of gadolinium contrast agents for magnetic resonance imaging in rats with osmotically disrupted blood-brain barrier. Takahashi M; Tsutsui H; Murayama C; Miyazawa T; Fritz-Zieroth B Magn Reson Imaging; 1996; 14(6):619-23. PubMed ID: 8897365 [TBL] [Abstract][Full Text] [Related]
36. Hepatic abscesses. Magnetic resonance imaging findings using gadolinium-BOPTA. Runge VM; Wells JW; Williams NM Invest Radiol; 1996 Dec; 31(12):781-8. PubMed ID: 8970881 [TBL] [Abstract][Full Text] [Related]
37. Comparison of Gd(DTPA-BMA) (Omniscan) versus Gd(HP-DO3A) (ProHance) relative to gadolinium retention in human bone tissue by inductively coupled plasma mass spectroscopy. White GW; Gibby WA; Tweedle MF Invest Radiol; 2006 Mar; 41(3):272-8. PubMed ID: 16481910 [TBL] [Abstract][Full Text] [Related]
38. Tissue relaxation enhancement after intravenous administration of (ITCB-DTPA)-gadolinum conjugated albumin, an intravascular magnetic resonance imaging contrast agent. Niemi P; Koskinen S; Reisto T Invest Radiol; 1991 Jul; 26(7):674-80. PubMed ID: 1885276 [TBL] [Abstract][Full Text] [Related]
39. Clearance of liposomal gadolinium: in vivo decomplexation. Unger EC; Fritz TA; Tilcock C; New TE J Magn Reson Imaging; 1991; 1(6):689-93. PubMed ID: 1823174 [TBL] [Abstract][Full Text] [Related]
40. Kinetics and magnetic resonance imaging of Gd-EOB-DTPA in dogs. Benness G; Khangure M; Morris I; Warwick A; Burrows P; Vogler H Invest Radiol; 1994 Jun; 29 Suppl 2():S177-8. PubMed ID: 7928221 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]